🦊/Investors

Hunniwell Lake Ventures LLC

Venture capital

Palo Alto · Seed–Series B · 6 people tracked

Find your way into Hunniwell Lake Ventures LLC

607 people in our graph share verified history with the Hunniwell Lake Ventures LLC team — schools, employers, funds. One of them is your warm intro.

Chris Mooreunlockedknows Daniel Teo · together at Stanford University Graduate School of Business (overlapped)
knows the team · via University of Cambridge
×5knows the team · via Stanford University Graduate School of Business
knows the team · via UC San Diego
×2knows the team · via University of Colorado Boulder - Leeds School of Business
knows the team · via BP
Fox Verdict
Sign up to see your fit

Investment thesis

Hunniwell Lake Ventures aims to help create market-leading, full-line medical device companies. The firm targets under-capitalized segments of the medical device space, seeking to introduce a new wave of innovation. Its stated goals include raising the quality of healthcare and making standard surgical procedures more accessible.

Source: firm website, verified Sep 15, 2026.

Stage
Seed–Series B
HQ
Palo Alto, California, US
Instruments
Equity
Founded
2019
Private fund assets
$621.9M
VC funds
6
Tracked investments
4
IPOs
1

Team · 6 people

from the firm's website & public directories

What they invest in

from 4 of 4 portfolio companies

Healthtech ×4Biotech ×3Medical Devices ×3Hardware ×2Deep Tech ×1

HQs:United States×3

Investments · 4 tracked

founders shown can be your intro path
Picard Medical, Inc.picardmedical.comin𝕏NYSE: PMI

Picard Medical is the parent company of SynCardia Systems, which develops and commercializes the SynCardia Total Artificial Heart (STAH), the only FDA and Health Canada-approved total artificial heart for patients awaiting donor hearts.

HealthtechMedical Devices

Dr. Jack CopelandRichard SmithDr. Marvin SlepianinRichard Fang(Interim Chief Executive Officer)in

Co-investorsHudson Bay

CoapTechcoaptech.comin

CoapTech makes the PUMA-G System, an FDA-cleared ultrasound-based device for bedside feeding tube (gastrostomy) placement, used in ICUs, step-down units, IR suites, and long-term acute care hospitals.

BiotechHardwareHealthtechMedical DevicesBaltimore, US

Steven Tropello(Executive Officer, Director)inHoward Carolan(Executive Officer, Director)in

BoardJohn Osborne(Director)inPeter Boyd(Director)William Walker(Director)Tim Collins(Director)

Co-investorsGood Growth Capital

NuvOx Pharmanuvoxpharma.comin

NuvOx Pharma is a clinical-stage pharmaceutical company developing NanO₂, an oxygen therapeutic drug intended to improve oxygen delivery from lungs to blood and to tissue in order to reverse tissue hypoxia.

BiotechHealthtech

Co-investorsBand of AngelsPasadena Angels

Syncardiasyncardia.comin𝕏Sep 2014

SynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant.

BiotechDeep TechHardwareHealthtechMedical DevicesTucson, US

Jack G. Copeland, M.D.(Director)Jack G. CopelandRichard G. SmithMarvin J. SlepianinMichael Garippa(Executive Officer, Director)inLuis Burgos(Executive Officer)

Exits · 1

1 IPOs

Picard Medical, Inc.NYSE: PMI

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Hunniwell Lake Ventures LLC invest at?
Hunniwell Lake Ventures LLC invests at the Seed, Series A, Series B stages.
What sectors does Hunniwell Lake Ventures LLC focus on?
Hunniwell Lake Ventures LLC focuses on Healthtech, Medical Devices.
Where is Hunniwell Lake Ventures LLC located?
Hunniwell Lake Ventures LLC is headquartered in Palo Alto, US.

Images

Hunniwell Lake Ventures LLC photoHunniwell Lake Ventures LLC photoHunniwell Lake Ventures LLC photo

Similar investors

Featured in lists